Clinical Trials Logo

Clinical Trial Summary

The overall goal of this study is to detect preclinical signs of HAPE by lung ultrasonography and evaluate the effectiveness of acetazolamide at decreasing pulmonary edema by using ultrasound.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03490916
Study type Interventional
Source University of Massachusetts, Worcester
Contact
Status Terminated
Phase Phase 4
Start date March 23, 2018
Completion date April 4, 2018

See also
  Status Clinical Trial Phase
Completed NCT00627965 - Randomized, Controlled Trial of Regular Sildenafil Citrate in the Prevention of Altitude Illness Phase 4
Recruiting NCT04288219 - Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary Edema N/A
Completed NCT00559442 - Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction N/A
Active, not recruiting NCT01565603 - Sleep and Cerebral Responses to High Altitude N/A
Completed NCT00274430 - Prevention of High Altitude Pulmonary Edema Phase 1/Phase 2
Recruiting NCT06039475 - RISK FACTORS ASSOCIATED WITH HIGH ALTITUDE SICKNESS: A CASE-CONTROL STUDY
Completed NCT04186598 - Evaluating the Utility of Continuous Positive Airway Pressure in the Treatment of High Altitude Pulmonary Edema N/A
Recruiting NCT01698619 - Hemodynamic Changes in Altitude Adaptation N/A
Not yet recruiting NCT04710953 - Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE N/A